Introduction to Journal Citation Reports 2024

One Journal, One Rank
Join this free webinar on Jul 16 on 11:00AM IST
Clarivate has released the 2024 update to the Journal Citation Reports™ (JCR), offering a comprehensive resource of high-quality journals ranked by field.

Key updates include the integration of the Emerging Sources Citation Index and the introduction of unified rankings across subject categories.

This means journals indexed in multiple categories will now have a single ranking.

Key Highlights of the 2024 JCR Release:
  • Enhanced user experience with the integration of journals from the Emerging Sources Citation Index.
  • Coverage includes over 21,800 journals, with about 5,800 open access journals.
  • Scholarly journals from 113 countries across 254 categories are recognized, with 544 journals receiving a Journal Impact Factor (JIF) for the first time.
Topics Covered in the Webinar:
  1. Expanding the Journal Impact Factor (JIF)
    • Inclusion of new indices like the Arts & Humanities Citation Index™ and Emerging Sources Citation Index™.
  2. Displaying the JIF
    • JIF will now be displayed to one decimal place, simplifying comparison.
  3. Understanding Journal Performance Data:
    • Deep dive into the data supporting journal performance metrics
    • Learn how to interpret and leverage this data for informed decision-making.
  4.  Employing a Wide Array of Metrics:
    • Overview of diverse metrics and descriptive statistics used in journal assessments
    • Explanation of the Journal Citation Indicator™.
  5. Responsible Use of JCR Metrics:
    • Guidelines and best practices for using JCR metrics responsibly.
    • Ethical considerations for employing these metrics in evaluations.
The webinar aims to help researchers, librarians, and academic professionals navigate the new features of JCR and utilize its data for journal assessment, emphasizing expanded coverage, refined impact factor presentation, and responsible metric usage.

Register below and we'll send the details.

HIDDEN FIELDS BELOW

Speaker

Dr. Subhasree Nag
Senior Business Solution Consultant
Clarivate

Dr.  Subhasree  Nag  is  a  senior  business  solution  consultant  for  the scholarly research and life sciences division at Clarivate.  

She  completed  her  PhD  from  Texas  Tech  University  Health  Sciences Center,  USA  and  her  post-doctoral  training  from  Pacific  Northwest National Laboratory, USA.

A pharmacologist and toxicologist by training, she has more than 8 years of  research  experience  in  anticancer  drug  discovery  and pharmacokinetics  areas  with  25  peer  reviewed  publications  and  more than 1500 citations.

At Clarivate, she is involved in promoting Clarivate's scholarly research, drug discovery and intellectual property (IP) solutions, conducting author and research capacity workshops, bespoke consulting projects, etc.

She  was  a  co-author  on  the  UGC-Good  Academic  Research  Practices guidance  document released  in  2020.  She  also  writes for  the  Clarivate pharma  industry  magazine,  Bioworld,  where  she  contributes  to  articles related to early-stage discovery and preclinical studies.